Ian White, Ph.D.
Chief Executive Officer and Chief Scientific Officer @ Neobiosis
About
Dr. White is considered a leading expert in the field of aging and regenerative medicine with 20 years’ experience working with stem cells, regenerative cells and tissue regeneration. Dr. White received degrees from Liverpool University prior to being recruited to Harvard University to work with hematopoietic stem cells (HSC) and immune cell biology. Dr. White went on to receive his Ph.D. in BioPhysics from the Ansary Stem Cell Institute, Division of Regenerative Medicine at Cornell University. During this time Dr. White developed an in vitro method for culture expanding autologous stem cells in an artificial vascular niche for the treatment of cancer patients who have undergone bone marrow ablation following chemo- or radio-therapy. This technology has since gone on to be commercialized by Cornell University.Since his Ph.D. Dr. White spent some time in the embryonic stem cell (ESC) laboratory of Dr. Stephen Dalton, who’s pioneering work led to the inclusion of c-myc as one of the 4 factors used by Nobel award winning Dr. Shinya Yamanaka in the generation of induced pluripotent stem cells (iPSCs).Subsequently, Dr. White relocated to the Interdisciplinary Stem Cell Institute at the University of Miami’s Miller School of Medicine. Dr. White published ground-breaking research in the field of regenerative medicine alongside Dr. Joshua Hare, including a book chapter on the use of Mesenchymal Signaling Cells (MSCs) in Cardiology. In 2015 Dr. White’s work on the regeneration of the heart was featured on the cover of Circulation Research, one of the top peer-reviewed journals for cardiovascular medicine in the world. In 2016 Dr. White was honored with an award for the “Best Manuscript” by the American Heart Association for his work highlighting the role of peripheral nerves in cardiac regeneration. In 2018 Dr. White joined with IMAC Regeneration Centers as their Chief Scientific Officer to take them public on NASDAQ. Dr. White currently sits as the CEO and CSO of NeoBiosis, LLC a perinatal regenerative tissue research and manufacturing facility, and serves as the vice president and member of the board of directors of the American College of Regenerative Medicine. Dr. White is the founder of the Space-Aging Research Institute (SARI) where his research is focused on the role of entropy in the aging of living organisms.
-
United States
Hospital & Health Care
Biochemistry, Immunology, Genetics, Tissue Culture, Stem Cells, Science, Cancer, Laboratory, Statistics, Data Analysis, Research, Product Development, Marketing, Leadership, Biology, Social Media, Public Speaking, Lifesciences, Biotechnology, Life Sciences
Experience

Chief Executive Officer and Chief Scientific Officer
Gainesville, Florida, United States
Our mission is to help redefine the field of regenerative medicine through regenerative science and shape the future of this fledgling industry through meaningful partnerships and collaborations.

Ethics Committe Board Member
The Bahamas
The government of the Bahamas Longevity and Regenerative Therapies Unit grants ethics approvals and licenses for longevity and regenerative therapy programs. The LARTA Agency, exclusively mandated by the Ministry of Health & Wellness, manages all applications through its digital portal and supports companies in navigating the regulatory process.

Vice President and Member of the Board of Directors of the American College of Regenerative Medicine
South Carolina, United States
The American College of Regenerative Medicine is a 501(c)6 non-profit professional society representing the diverse community of people, businesses, and organizations participating in the field of regenerative medicine.

Chief Scientific Officer
IMAC Regeneration Centers
Miami/Fort Lauderdale Area
Innovative Medical Advancements and Care Regeneration Centers. Fixing bodies without surgery or opioids. The #1 solution for the opioid epidemic in the US, by combining regeneration and rehabilitation. We took IMAC public in February 2019. Nasdaq ticker - imac.

Founder
BioFirma, LLC
Miami/Fort Lauderdale Area
BioFirma was an FDA registered perinatal cell and exosome research and manufacturing facility. BioFirma became Neobiosis in 2020.
Education

Applied Parasitology and Medical Entomology
Liverpool School of Tropical Medicine. Study - human parasitology, comparative parasitology, immunology of parasitic infections, medical entomology, vector biology, parasite ecology and epidemiology, experimental biology and biosystematics, statistics.
Ian White, Ph.D.'s Contact Information
Phone
Find the Right Leads
Find Verified Contact Data
What LeadContact does well
Find verified emails, phone numbers, and decision-makers with 98% accuracy.
Find Leads
Find the right people by company, role, industry, location, and more.
925M+ professional profiles

Find Emails
Access verified email addresses for your target contacts.
657M+ emails

Find Phone Numbers
Get cross-validated phone data from multiple top sources.
239M+ phone numbers

More Accurate. Lower Cost.
Find contact data in 1 tool with 98% accuracy
LeadContact integrates leading enrichment tools to deliver more accurate contact data—without paying for each one.
Great conversations start with the right contact.
It’s time to find yours.







